Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Matrix Metalloproteinase-2 in Platelet Adhesion to Fibrinogen: Interactions With Nitric Oxide

Alfredo Martinez, Eduardo Salas, Anna Radomski, Marek W Radomski

Med Sci Monit 2001; 7(4): BR646-651 :: ID: 421090

Abstract

BACKGROUND: Matrix metalloproteinase-2 (MMP-2) has been shown to activatea non-thromboxane, non-ADP pathway of platelet aggregation. In contrast, nitric oxide (NO) is known toinhibit platelet adhesion and aggregation. Therefore, we have studied the release of MMP-2 during plateletadhesion to fibrinogen, the effects of phenanthrolione, an MMP-2 inhibitor, on adhesion and the interactionsof inhibitor with a NO donor, S-nitroso-N-acetyl-D, L-penicillamine (SNAP).
MATERIAL AND METHODS: Humanplatelets were isolated from blood of healthy volunteers and platelet adhesion to fibrinogen-coated plateswas studied by measuring thrombin-stimulated release of platelet a-granule constituent, platelet factor4. In addition, the mode of action of phenanthroline and NO on platelets was investigated by assayingthe levels of intraplatelet cyclic GMP.
RESULTS: Thrombin-stimulated platelet adhesion to fibrinogen wasassociated with increased release of MMP-2 from platelets. Phenanthroline (0.1-100 KM) reduced plateletadhesion to fibrinogen. The adhesion was also inhibited by SNAP (0.1-100 KM), an effect abolished by1H-[1,2,4] oxadiazolol [4,3,-a] quinoxalin-1-one (ODQ), a selective inhibitor of the soluble guanylatecyclase. Co-administration of phenanthroline and SNAP resulted in a synergistic inhibition of plateletadhesion, an effect that was not associated with enhanced cyclic GMP generation by platelets. Furthermore,ODQ did not reverse the synergistic effect of these compounds on adhesion.
CONCLUSIONS: 1. MMP-2 promotesplatelet adhesion to fibrinogen. 2. Phenanthroline and NO synergize to inhibit platelet adhesion to fibrinogenacting through a cyclic GMP-independent mechanism(s).

Keywords: Matrix metalloproteinase-2, Nitric Oxide, platelet adhesion

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750